These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11523071)

  • 1. Non-parametric analysis of covariance for confirmatory randomized clinical trials to evaluate dose-response relationships.
    Tangen CM; Koch GG
    Stat Med; 2001 Sep 15-30; 20(17-18):2585-607. PubMed ID: 11523071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them.
    Koch GG; Tangen CM; Jung JW; Amara IA
    Stat Med; 1998 Aug 15-30; 17(15-16):1863-92. PubMed ID: 9749453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-parametric covariance methods for incidence density analyses of time-to-event data from a randomized clinical trial and their complementary roles to proportional hazards regression.
    Tangen CM; Koch GG
    Stat Med; 2000 Apr; 19(8):1039-58. PubMed ID: 10790679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 May; 9(2):307-38. PubMed ID: 10379696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomization-based nonparametric methods for the analysis of multicentre trials.
    LaVange LM; Durham TA; Koch GG
    Stat Methods Med Res; 2005 Jun; 14(3):281-301. PubMed ID: 15969304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
    Musini VM; Nazer M; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary nonparametric analysis of covariance for logistic regression in a randomized clinical trial setting.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 Mar; 9(1):45-66. PubMed ID: 10091909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing non-inferiority with time-to-event data via the method of non-parametric covariance.
    Zhang X; Xu J; He J
    Stat Methods Med Res; 2013 Jun; 22(3):346-60. PubMed ID: 21705437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide.
    Kjeldsen SE; Os I; Høieggen A; Beckey K; Gleim GW; Oparil S
    Am J Cardiovasc Drugs; 2005; 5(1):17-22. PubMed ID: 15631534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials.
    Hung HM
    Stat Med; 2000 Aug; 19(16):2079-87. PubMed ID: 10931512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
    Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C
    Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
    Chrysant SG; Stimpel M
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):384-90. PubMed ID: 9514183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the efficacy of fixed-dose combinations olmesartan medoxomil/hydrochlorothiazide and amlodipine besylate/benazepril in factorial design studies.
    Quan A; Chavanu K; Merkel J
    Am J Cardiovasc Drugs; 2006; 6(2):103-13. PubMed ID: 16555863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.